Huaxin Science and Technology Approves Removal of Competition Restrictions for New Directors at Shareholders' Meeting

Release Date: 1150624 Announcement Date: 1150623 Announcement Time: 14:09:14 Company Code: 3059 Company Name: Huaxin Science and Technology Subject: Announcement of the Passing of the Resolution to Remove Competition Restrictions for New Directors at the 115th Annual General Meeting Applicable Clause: Clause 21 Date of Fact: 1150623 Explanation: 1. Date of Shareholders' Meeting Resolution: 115/06/23 2. Names and Titles of Directors Permitted to Engage in Competitive Activities: (1) Director: Xia Ruwen (2) Director: Chen Mengfen (3) Representative of Xichang International Limited: Ding Yujia (4) Representative of Xichang International Limited: Liang Minfang 3. Items Permitted to Engage in Competitive Activities: (1) Director: Xia Ruwen Director of Altek Medical Pte. Ltd. Director of Altek Medical Sdn. Bhd. Chairman of Rongjing Biotechnology Co., Ltd. Director of Rongjing Medical (Hong Kong) Limited Executive Director of Rongjing Biotechnology (Shanghai) Limited Executive Director of Rongjing Medical Technology (Kunshan) Limited Chairman of Kunshan Dejing Optoelectronics Technology Co., Ltd. (2) Director: Chen Mengfen Supervisor of Rongjing Biotechnology (Shanghai) Limited Supervisor of Rongjing Medical Technology (Kunshan) Limited Independent Director of Earth Comprehensive Industry Co., Ltd. Director of Junduan Technology Co., Ltd. (3) Representative of Xichang International Limited: Ding Yujia Independent Director of Yingzheng Yushun Electronics Co., Ltd. Independent Director of Huagu Construction Co., Ltd. (4) Representative of Xichang International Limited: Liang Minfang Independent Director of He Ruiya Technology Co., Ltd. 4. Period Permitted to Engage in Competitive Activities: During the tenure as a director of the company 5. Resolution Situation (Explanation of Voting Results Based on Company Law Article 209): This proposal was passed with the approval of more than two-thirds of the voting rights of the shareholders present, who represented more than half of the total issued shares. 6. Names and Titles of Directors (If the Permitted Competitive Activities Apply to Mainland China Businesses; Otherwise, Please Enter 'Not Applicable'): (1) Director: Xia Ruwen (2) Director: Chen Mengfen 7. Names and Titles of Mainland China Businesses: (1) Director: Xia Ruwen Rongjing Biotechnology (Shanghai) Limited / Director Rongjing Medical Technology (Kunshan) Limited / Director Kunshan Dejing Optoelectronics Technology Co., Ltd. / Chairman (2) Director: Chen Mengfen Rongjing Biotechnology (Shanghai) Limited / Supervisor Rongjing Medical Technology (Kunshan) Limited / Supervisor 8. Addresses of Mainland China Businesses: Rongjing Biotechnology (Shanghai) Limited: Room 722, C Area, 1st Floor, Building 1, No. 58, Dijie Road, Baoshan District, Shanghai Rongjing Medical Technology (Kunshan) Limited: Room 2, Building 1, No. 77, Third Avenue, Export Processing Zone, Kunshan Development Zone, Jiangsu Province Kunshan Dejing Optoelectronics Technology Co., Ltd.: No. 77, 3rd Avenue, Kunshan Comprehensive Bonded Zone, Kunshan City, Jiangsu Province 9. Business Items of Mainland China Businesses: Rongjing Biotechnology (Shanghai) Limited: Sales of medical electronic equipment Rongjing Medical Technology (Kunshan) Limited: Production services of medical electronic equipment Kunshan Dejing Optoelectronics Technology Co., Ltd.: Manufacturing and sales of optical electronic components, optical instruments, cameras, and related equipment 10. Impact on the Company's Financial and Business Operations: Not Applicable 11. Investment Amount and Shareholding Ratio (If Directors Have Invested in Mainland China Businesses): None 12. Other Matters to be Stated: None